Literature DB >> 29060062

Safe Direct Current Stimulator design for reduced power consumption and increased reliability.

Gene Fridman.   

Abstract

Current state of the art neural prosthetics, such as cochlear implants, spinal cord stimulators, and deep brain stimulators use implantable pulse generators (IPGs) to excite neural activity. Inhibition of neural firing is typically indirect and requires excitation of neurons that then have inhibitory projections downstream. Safe Direct Current Stimulator (SDCS) technology is designed to convert electronic pulses delivered to electrodes embedded within an implantable device to ionic direct current (iDC) at the output of the device. iDC from the device can then control neural extracellular potential with the intent of being able to not only excite, but also inhibit and sensitize neurons, thereby greatly expanding the possible applications of neuromodulation therapies and neural interface mechanisms. While the potential applications and proof of concept of this device have been the focus of previous work, the published descriptions of this technology leave significant room for power and reliability optimization. We describe and model a novel device construction designed to reduce power consumption by a factor of 12 and to improve its reliability by a factor of 8.

Entities:  

Mesh:

Year:  2017        PMID: 29060062      PMCID: PMC5911345          DOI: 10.1109/EMBC.2017.8037015

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  9 in total

1.  Direct current electrical conduction block of peripheral nerve.

Authors:  Niloy Bhadra; Kevin L Kilgore
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2004-09       Impact factor: 3.802

Review 2.  Bionic vision: system architectures: a review.

Authors:  Thomas Guenther; Nigel H Lovell; Gregg J Suaning
Journal:  Expert Rev Med Devices       Date:  2012-01       Impact factor: 3.166

Review 3.  Electrical stimulation of excitable tissue: design of efficacious and safe protocols.

Authors:  Daniel R Merrill; Marom Bikson; John G R Jefferys
Journal:  J Neurosci Methods       Date:  2005-02-15       Impact factor: 2.390

4.  High frequency mammalian nerve conduction block: simulations and experiments.

Authors:  Kevin L Kilgore; Niloy Bhadra
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2006

5.  Safe direct current stimulator 2: concept and design.

Authors:  Gene Y Fridman; Charles C Della Santina
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

6.  Electrical stimulation with Pt electrodes. VIII. Electrochemically safe charge injection limits with 0.2 ms pulses.

Authors:  T L Rose; L S Robblee
Journal:  IEEE Trans Biomed Eng       Date:  1990-11       Impact factor: 4.538

7.  Safe direct current stimulation to expand capabilities of neural prostheses.

Authors:  Gene Y Fridman; Charles C Della Santina
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2013-03       Impact factor: 3.802

8.  Relation between discharge regularity and responses to externally applied galvanic currents in vestibular nerve afferents of the squirrel monkey.

Authors:  J M Goldberg; C E Smith; C Fernández
Journal:  J Neurophysiol       Date:  1984-06       Impact factor: 2.714

9.  Cochlear implants: a remarkable past and a brilliant future.

Authors:  Blake S Wilson; Michael F Dorman
Journal:  Hear Res       Date:  2008-06-22       Impact factor: 3.208

  9 in total
  3 in total

1.  Combined ionic direct current and pulse frequency modulation improves the dynamic range of vestibular canal stimulation.

Authors:  F P Aplin; D Singh; C C Della Santina; G Y Fridman
Journal:  J Vestib Res       Date:  2019       Impact factor: 2.435

2.  Direct current effects on afferent and hair cell to elicit natural firing patterns.

Authors:  Cynthia R Steinhardt; Gene Y Fridman
Journal:  iScience       Date:  2021-02-20

Review 3.  Implantable Direct Current Neural Modulation: Theory, Feasibility, and Efficacy.

Authors:  Felix P Aplin; Gene Y Fridman
Journal:  Front Neurosci       Date:  2019-04-18       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.